Heterologous vaccination from 16 July on Following an advisory report by the Health Council, Minister De Jonge decided on 6 July 2021, effective as of 16 July, that people who had received one vaccination with AstraZeneca could opt for the Pfizer/BioNTech for their second jab.
Vaccination coverage is rising, while data is increasingly comprehensive The RIVM vaccination update this week has been expanded to include vaccination coverage by municipality, specifying full COVID-19 vaccination among people aged 65 and over and people aged 45-64 years.
Long COVID also possible after a mild case: interim research results More than 95% of the 1,741 participants in RIVM’s LongCOVID study, who reported long-term symptoms after COVID-19, had mild symptoms during the acute phase of the infection.
Antimicrobial resistance in the Netherlands stable in 2020 In 2020, the year of the coronavirus SARS-CoV-2 pandemic, resistant bacteria were not found more often in patients in the Netherlands than before the outbreak.
Vaccination turnout for people aged 45-64 by municipality: 79% vaccinated at least once For the first time, the new RIVM vaccination update shows vaccination turnout for people aged 45-64 years per municipality.
Menthol facilitates inhalation of tobacco smoke, even when you cannot taste it Even when menthol cannot be tasted, the substance makes it easier to inhale tobacco smoke. This way, menthol makes smoking more attractive for young and novice smokers who are not yet used to inhaling sharp, pungent tobacco smoke.
Exploratory study on continuation of COVID-19 Vaccination Programme RIVM has commissioned ABDTOPconsult to do an independent exploratory study on systematic approaches to organising and incorporating the current RIVM COVID-19 Vaccination Programme.
Early indicators added to coronavirus monitoring in sewage on Coronavirus Dashboard This week, early indicators were added to the sewage measurements page on the Coronavirus Dashboard provided by the national government. These values help to clarify the measurements by indicating how serious the situation is.
Delta variant on the rise The delta variant of the coronavirus SARS-CoV-2 is occurring more and more often in the Netherlands.
COVID-19 vaccination very effective: major drop in positive tests, hospital admissions and deaths among older people People over 75 years old living at home are 82% protected against testing positive for COVID-19 from three weeks after the second vaccination.